🕵️ Verrica Pharmaceuticals Inc. ($VRCA)
SEC insider & ownership activity, last 12 months · CIK 1660334 · every row links its SEC filing
Over the last 12 months insiders bought $18.2M with no open-market selling against it. Paul B. Manning bought $17.5M in discretionary trades (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
5 buyers, $18.2M (12 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Paul B. Manning | 2 | $17.5M | 0 | – | Nov 25, 2025 |
| Rieger Jayson | 3 | $526K | 0 | – | Aug 17, 2026 |
| Zawitz David | 2 | $72K | 0 | – | Aug 17, 2026 |
| Noah L. Rosenberg | 3 | $41K | 0 | – | Aug 18, 2026 |
| John J. Kirby | 2 | $40K | 0 | – | Aug 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Paul B. Manning | 49.9% | 13D | Nov 25, 2025 | filing ↗ | |
| BKB Growth Investments, LLC | 20.9% | 13D | Nov 25, 2025 | filing ↗ | |
| David Johnson | 10.0% | 13D | Dec 26, 2025 | filing ↗ | |
| Caligan Partners LP | 10.0% | 13D | Dec 26, 2025 | filing ↗ | |
| Affinity Asset Advisors, LLC | 5.5% | 13G | Jan 29, 2026 | filing ↗ | |
| Michael Cho | 5.5% | 13G | Jan 29, 2026 | filing ↗ | |
| Affinity Healthcare Fund, LP | 5.5% | 13G | Dec 3, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 23, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 23, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Nov 23, 2025 | filing ↗ |
| Other events (8.01) | Nov 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 23, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |